# IceCure Medical (ICCM) — Earnings

ICCM · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/iccm/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$1.80 |
| EPS estimate | −$1.52 |
| EPS surprise | −18.68% |
| Revenue surprise | −23.47% |
| Revenue | $1.1M |
| Revenue estimate | $1.5M |
| Reported | Aug 12, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1584371/000121390026088071/ea0301287-6k_icecure.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/6317c19b-99ee-8f67-db9a-3e878512cea2.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 12, 2026 | −$1.52 | −$1.80 | -18.68% | $1.5M | $1.1M |
| Q1 2026 | May 12, 2026 | −$1.40 | −$1.80 | -28.57% | $1.3M | $911,000.00 |
| Q4 2025 | Mar 17, 2026 | −$1.50 | −$1.50 | 0.00% | $1.3M | $1.3M |
| Q3 2025 | Nov 19, 2025 | −$1.50 | −$1.80 | -20.00% | $714,000.00 | $850,000.00 |
| Q2 2025 | Aug 13, 2025 | −$1.93 | −$1.80 | 6.89% | $662,500.00 | $525,000.00 |
| Q1 2025 | May 28, 2025 | −$2.35 | −$1.77 | 25.00% | $750,000.00 | $725,000.00 |
| Q4 2024 | Mar 27, 2025 | −$2.21 | −$2.35 | -6.67% | $1.1M | $875,000.00 |
| Q3 2024 | Nov 26, 2024 | −$2.21 | −$2.35 | -6.67% | $708,500.00 | $662,000.00 |
| Q2 2024 | Aug 20, 2024 | −$2.06 | −$1.77 | 14.28% | $925,500.00 | $1.0M |
| Q1 2024 | May 28, 2024 | −$2.26 | −$2.35 | -4.35% | $1.0M | $743,000.00 |
| Q4 2023 | Apr 3, 2024 | −$2.06 | −$1.77 | 14.28% | $1.2M | $1.3M |
| Q3 2023 | Invalid Date | −$2.65 | −$2.65 | 0.00% | $1.0M | $327,000.00 |
| Q2 2023 | Invalid Date | −$2.55 | −$2.65 | -3.85% | $934,333.00 | $937,000.00 |
| Q1 2023 | May 22, 2023 | −$2.75 | −$2.35 | 14.29% | $950,000.00 | $710,000.00 |

## Frequently Asked Questions

### When did IceCure Medical (ICCM) last report earnings?

IceCure Medical last reported on Aug 12, 2026, covering fiscal Q2 2026.

### Did ICCM beat earnings estimates?

No. IceCure Medical reported EPS of −$1.80 for Q2 2026 against a −$1.52 estimate — a 18.68% miss.

### How much revenue did ICCM report last quarter?

IceCure Medical reported $1.1M in revenue for Q2 2026, against a consensus estimate of $1.5M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).